The Food and Drug Administration approved the first-ever weight-loss pill on Monday, a move that is set to greatly expand the industry.
Novo Nordisk’s GLP-1 weight-loss pill is a tablet formulation of the popular Ozempic and Wegovy. The drugs previously could only be taken via injection, a discomforting method for many users. Its transformation into a convenient pill is almost certain to lead to increased usage of the drug.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
